Actavis
Pendapatan operasi | ▲ US$1.090 bilion (2014) |
---|---|
Industri | Branded and generic pharmaceuticals, and pharmaceutical research and development |
Tempat dibekalkan | ~100 negara |
Jumlah aset | ▲ US$6.881 bilion (2014) |
Bilangan kawasan | 40 manufacturing facilities, 27 global R&D centers and marketing/sales facilities worldwide |
Pendapatan bersih | ▼ -US$1.630 bilion (2014) |
Bilangan pekerja | 21,600 (Feb. 2015) |
Induk | Teva Pharmaceutical Industries |
Jumlah ekuiti | ▲ US$28.335 bilion (2014) |
Perancang utama | Brenton L. Saunders (CEO, Presiden) Paul Bisaro, Pengerusi Eksekutif |
Ibu pejabat | Dublin, Ireland dan Parsippany-Troy Hills, New Jersey, A.S. |
Pengasas | Allen Chao, Ph.D. dam David Hsia, Ph.D. |
Laman sesawang | www.actavis.com |
Keluaran | Branded and generic pharmaceuticals |
Ditubuhkan | Mac 1984; 35 tahun yang lalu (1984-03) di Libertyville, Illinois, Amerika Syarikat |
Hasil | US$13.062 bilion (2014) |
Pendahulu | Allergan, Inc. |
Jenis | Anak syarikat |